成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook Chinese Germany Japanese Korean

山東博洛達生物科技有限公司 Company Information

Company Name:    Shandong Boluoda Biological Technology Co., Ltd.
Tel:    0531-68652053
Email:    2310993908@qq.com
Nationality:    China
WebSite:    boluoda.com/indel.html
Product List:    1556
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Product List
Sodium picosulfate M1Z1 16985-05-0
Deoxysepiapterin 1797-87-1
3R, 5R epimer (impurity b)
Salkeliptin impurity k
Salkeliptin impurity q
Omadacycline Impurity 3YWP-IM-03 2272886-35-6
Amlodipine Impurity D 113994-41-5
Levofloxacin Impurity D 178964-53-9
Ceftriaxone EP impurity A 97164-54-0
Bupropion Related Compound A HCl 1049718-72-0
Nicergoline Impurity A 38536-28-6
Linezolid ImpurityLNZA-E 1391068-25-9
Calcium Levofolinate Impurity 39707-61-4
Lysine Acetylsalicylate Impurity H 121893-23-0
formaldehyde O-methyl oxime 62479-73-6
Trimetazidine Impurity 92432-50-3
Salkeliptin impurity b
Salkeliptin impurity h
Omadacycline Impurity 2YWP-IM-02 885112-31-2
Tryptophan EP Impurity F 145545-23-9
Diltiazem EP Impurity B 87447-47-0
5,6-trans Travoprost 1563176-59-9
Afzosin hydrochloride impurity e
Apatamide impurity 2 133239-92-0
Argatroban Impurity I 189264-02-6
2-Hydroxypropylcarbamate 17464-96-9
Ilaprazole Impurity 1378653-43-0
3S, 5S epimer (impurity b)
Afzosin hydrochloride impurity a
Salkeliptin impurity o
Sugammadex Org226100-1 2768160-22-9
Vitamin K1 Impurity G 34044-00-3
1-Propanol, 2-(2-hydroxypropoxy)-, 1-carbamate 2271317-97-4
1-hydroxypropyl-2-yl-Carbamate 36473-03-7
Linagliptin Impurity 106 1955514-80-3
Decarbamoylcefoxitin Cefoxitin Impurity E 2395025-32-6
Empagliflozin Impurity 25 2452301-42-5
Starting material II (impurity n)
Salkeliptin impurity l
Salkeliptin impurity r
Omadacycline Impurity 1YWP-IM-01 601455-29-2
Duloxetine Related Compound H 199191-66-7
Bupropion Related Compound B HCl 1049718-43-5
Salbutamol Impurity L 149222-15-1
Dapagliflozin peroxide impurit 2452300-94-4
Salkeliptin impurity c
Salkeliptin impurity i
2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridin-4(1H)-one 301669-82-9
(3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydrosy-6-heptane acid,(+)phenyl ethylamine 147511-70-4
Atorvastatin Impurity 906552-18-9
BOlmesartan Medoxomil EP Impurity B 849206-43-5
Ezetimibe tetrahydropyran Impurity 56 1296129-15-1
Oseltamivir Impurity 1415963-60-8
Brexpiprazole Impurity 913612-07-4
Lubiprostone enantioMer Impurity 1217675-13-2
Upadacitinib Impurity 15 2304514-60-9
Indapamide Impurity A 85440-79-5
Demethylation impurity
Salkeliptin impurity e
Salkeliptin impurity 361442-04-8
Levofloxacin N-oxide 117678-38-3
Betahistine Impurity 9 6304-27-4
Esomeprazole Impurity 2362529-32-4
Rosuvastatin tert butyl propionate (impurity f)
Salkeliptin impurity m
Paliperidone Impurity 913728-83-3
Urea, N-(1-hydroxyethyl)- 16395-94-1
Sulbactam Impurity C 75527-87-6
Afzosin hydrochloride impurity D
Ticagrelor Impurity SIP-1 2096989-56-7
Mometasone Furoate EP Impurity H 148596-90-1
Ethyl Lipoicate Impurity 46353-61-1
1,1,5,5-Tetramethyl-2-(1-methylethenyl)cyclohexane 63251-38-7
Salkeliptin impurity d
Salkeliptin impurity j
Salkeliptin impurity p
Linagliptin Impurity V 2468656-63-3
Omadacycline Impurity 6YWP-IM-06 488819-64-3
Atorvastatin Calcium Impurity Ⅵ 873590-19-7
Dapagliflozin Impurity A 1373321-04-0
Norepinephrine Impurity 9 1891319-98-4
Afzosin hydrochloride impurity 81403-68-1
Salkeliptin impurity f
Salkeliptin impurity a
Salkeliptin impurity g
ValsartanEP Impurity A 137862-87-4
Levonorgestrel Impurity 5 17092-07-8
Clavulanic acid Impurity C 86917-74-0
Afzosin hydrochloride impurity B
Cefaclor EP Impurity C 143059-69-2
Azacitidine α-Isomer Impurity 157771-77-2
Bisoprolol Hydroxyethyl Ester Impurity D 1346601-19-1
Vonoprazan Impurity Imp-47 2416241-97-7
Amlodipine EP Impurity D 2138811-33-1
Epalrestat (E,E)-Isomer 863988-85-6
DL-Pantothenic acid calcium salt 6381-63-1
Enantiomer (impurity g)
Tert butyl rosuvastatin (impurity m)
Salkeliptin impurity n
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Copyright 2007©  ChemicalBook. All rights reserved.